UROVANT SCIENCES LTD's ticker is UROV and the CUSIP is G9381B108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $765,000 | – | 47,401 | – | 0.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pekin Hardy Strauss, Inc. | 424,127 | $3,961,000 | 0.81% |
| Samsara BioCapital, LLC | 157,480 | $1,471,000 | 0.41% |
| Perceptive Advisors | 2,366,831 | $22,106,000 | 0.32% |
| Wildcat Capital Management, LLC | 94,687 | $884,000 | 0.28% |
| Vigilare Wealth Management | 13,000 | $121,000 | 0.13% |
| Alyeska Investment Group, L.P. | 620,889 | $5,799,000 | 0.09% |
| LVW Advisors, LLC | 38,812 | $363,000 | 0.08% |
| Baker Brothers Advisors | 978,505 | $9,139,000 | 0.04% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 51,100 | $477,000 | 0.01% |
| Marshall Wace North America L.P. | 42,546 | $397,000 | 0.00% |